News - MedTech

Cambridge BioTech raises £58m to target global markets

BioTech Maxion Therapeutics has raised a £58m Series A investment round to develop its technology a...

Listed Oncimmune crashes into administration

Oncimmune Holdings plc is to be placed into administration, with trading in its shares suspended. ...

Spinout raises £1.5m to tackle aggressive cancers

Ulster University spinout StimOxyGen has raised £1.5m to accelerate the development of its innovati...

AR firm Strolll, targeting neurological disorders, raises £10.4m

Digital therapeutic software company Strolll has raised £10.4m in a Series A funding round to accel...

Scottish BioTech raises funds to make cancer therapies accessible

Edinburgh-based BioTech Lentitek Ltd has secured £700,000 in private funding to make cancer therapi...

MedTech raises £500k for innovative diagnostic tests

Medical device business ReadyGo Diagnostics has raised £500,000 from the British Business Bank’s ...

Leeds MoD spinout secures £200k for infection detection tech

Presymptom Health has secured £200,000 in additional grant funding to speed-up its AI-driven infect...

Cambridge BioTech raises £5.5m to address $400bn annual issue

AI-driven drug turnaround company Ignota Labs has closed a £5.5m seed funding round to expand its p...

Cambridge Innovation Capital launches £100m Opportunity Fund

Cambridge Innovation Capital has launched a new £100m Opportunity Fund – anchored by Aviva Invest...

Listed Oncimmune seeks emergency funding

Oncimmune Holdings plc is seeking emergency funding to extend its cash runway beyond April. The L...

YFM backs MBO at audiology specialist

YFM Equity Partners has backed a management buyout at Audiological Science, one of the UK’s leadin...

BioTech bids to become latest firm to delist in London

BioTech Biome Technologies has announced its plans to stop its shares from trading on AIM and re-reg...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.